Professor Chris Molloy, CEO of Medicines Discovery Catapult (MDC), writes about the state of the UK’s drug discovery sector, exploring economic challenges and what is needed to support the country’s rich life sciences talent. We should all be proud of and inspired by the UK life sciences sector’s rich heritage. 25% of the world's […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!
